Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 26 Small Cell Lung Carcinoma 10 Sarcoma 8 Breast Neoplasms 8 Carcinoma, Hepatocellular 7 Lung Neoplasms 6 Stomach Neoplasms 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma 4 Non-squamous Non-small Cell Lung Cancer 3 NSCLC 3 Glioma 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Thyroid Neoplasms 2 Pheochromocytoma 2 Paraganglioma 2 Neoplasms 2 Liver Neoplasms 2 Gynecological Cancer 2 Extensive Stage Small Cell Lung Cancer 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Digestive System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Advanced Solid Tumor 2 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

niraparib 1 anlotinib 1 PHI-101 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Platinum-resistant Ovarian Cancer × anlotinib × Clear all

NCT04376073 2020-11-25

ANNIE

Sun Yat-sen University

Phase 2 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡